Acute Kidney Injury (AKI) identified by a biochemistry based electronic alert: An Epidemiological Study


Acute Kidney Injury (AKI) is a syndrome characterised by an abrupt loss of renal function, and can be identified using a unique biomarker, Serum Creatinine. AKI is considered a major global health issue and is associated with poor patient outcomes and prolonged lengths of hospital stay. In 2009, a report by the National Confidential Enquiry into Patient Outcome and Death (NCEPOD) identified significant deficiencies in the management of AKI in hospitals in the UK. Based on a presumption that early identification may help raise standards of care and improve patient outcomes, an automated real time electronic alerting system for AKI based on the Kidney Disease: Improving Global Outcomes (KDIGO) change in creatinine diagnostic criteria has been established and implemented nationally across all areas of the National Health Service in Wales.

Research areas:

1. Validation of an electronic alerting system for AKI

2. Use of an electronic alerting system for AKI to provide an epidemiological description of AKI

3. Application of an electronic alerting system for AKI as a health care policy decision making support tool

Miss Jennifer Holmes